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Uniformity of dosage units [1] is one of the most commonly
employed compendial tests to evaluate the dosage units. In
the test, the acceptance value (AV) is the key statistics-based
acceptance parameter with the limit of not more than 15 to
measure the uniformity degree of the dosage units in terms
of content uniformity or weight variation as applicable. With
quality assurance (QA) principle, there should be some
kinds of predetermined acceptance limits, like Bergum
method introduced by James S. Bergum in 1990 [2] and 2007
[3] and recently recognized by ASTM 2709 [4] and ASTM 2810
[5] to ensure that the AV results for any future quality
control (QC) samples will not exceed the compendial limit
(NMT 15).
Since AV is a kind of sample statistics, sampling distribu-
tion of the AV data can be plotted as AV distribution (Fig. 1).
To develop the AV probability density function (pdf) formula
is to derive from McKay’s coefficient of variation (CV) distri-
bution equation [6]. To confirm the validity of the formula is
to conduct a computer simulation using MS Excel program.
Fig. 1 also illustrates the successful simulation test result. One
of the key benefits of the constructed AV distribution is to es-
tablish the predetermined acceptance limit for AV results, say
the percentage point at 99% of the distribution (i.e. AV NMT
12), rather than directly using the compendial limit. For vali-
dation data (samples greater than QC samples), validation
acceptance criteria can be established as well.
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Acceptance Value (AV)
Acceptance Value Distribution (Simulation Test)
Simulated AV Distribution (n = 10, k = 
90000, N = 900000): AV Average = 7.05,
Max = 14.1, Min = 1.49, SD = 1.66, k 
Value = 2.4, Lot CpK = 1.67 
Theoretical AV Distribution (n = 10, k 
Value = 2.4): Mean = 7.13, SD = 1.67 
Fig. 1 – Acceptance Value (AV) Distribution.
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